Annual Shareholders Equity
$7.30 M
+$18.22 M+166.92%
December 31, 2023
Summary
- As of February 8, 2025, AVTX annual stockholders equity is $7.30 million, with the most recent change of +$18.22 million (+166.92%) on December 31, 2023.
- During the last 3 years, AVTX annual shareholders equity has fallen by -$17.26 million (-70.26%).
- AVTX annual shareholders equity is now -73.78% below its all-time high of $27.86 million, reached on December 31, 2017.
Performance
AVTX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$21.08 M
+$34.68 M+254.88%
September 30, 2024
Summary
- As of February 8, 2025, AVTX quarterly stockholders equity is $21.08 million, with the most recent change of +$34.68 million (+254.88%) on September 30, 2024.
- Over the past year, AVTX quarterly shareholders equity has increased by +$34.68 million (+254.88%).
- AVTX quarterly shareholders equity is now -58.33% below its all-time high of $50.58 million, reached on June 30, 2020.
Performance
AVTX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
AVTX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +166.9% | +254.9% |
| 3 y3 years | -70.3% | +293.1% |
| 5 y5 years | -65.1% | +15.7% |
AVTX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -68.4% | +166.9% | -8.7% | +120.8% |
| 5 y | 5-year | -70.3% | +166.9% | -58.3% | +120.8% |
| alltime | all time | -73.8% | +127.7% | -58.3% | +120.8% |
Avalo Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $21.08 M(-254.9%) |
| Jun 2024 | - | -$13.61 M(-86.5%) |
| Mar 2024 | - | -$101.08 M(-1484.0%) |
| Dec 2023 | $7.30 M(-166.9%) | $7.30 M(-50.3%) |
| Sep 2023 | - | $14.70 M(-310.9%) |
| Jun 2023 | - | -$6.97 M(+11.2%) |
| Mar 2023 | - | -$6.27 M(-42.6%) |
| Dec 2022 | -$10.91 M(-147.3%) | -$10.91 M(+438.2%) |
| Sep 2022 | - | -$2.03 M(-65.9%) |
| Jun 2022 | - | -$5.95 M(-193.8%) |
| Mar 2022 | - | $6.34 M(-72.5%) |
| Dec 2021 | $23.08 M(-6.0%) | $23.08 M(-42.7%) |
| Sep 2021 | - | $40.31 M(+86.7%) |
| Jun 2021 | - | $21.59 M(-34.9%) |
| Mar 2021 | - | $33.16 M(+35.0%) |
| Dec 2020 | $24.56 M(+17.0%) | $24.56 M(-36.3%) |
| Sep 2020 | - | $38.57 M(-23.7%) |
| Jun 2020 | - | $50.58 M(+97.7%) |
| Mar 2020 | - | $25.59 M(+21.9%) |
| Dec 2019 | $21.00 M | $21.00 M(+15.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $18.22 M(+3.0%) |
| Jun 2019 | - | $17.70 M(-23.5%) |
| Mar 2019 | - | $23.12 M(+10.6%) |
| Dec 2018 | $20.91 M(-25.0%) | $20.91 M(+7.2%) |
| Sep 2018 | - | $19.51 M(+1.5%) |
| Jun 2018 | - | $19.22 M(-21.8%) |
| Mar 2018 | - | $24.58 M(-11.8%) |
| Dec 2017 | $27.86 M(>+9900.0%) | $27.86 M(+25.9%) |
| Sep 2017 | - | $22.12 M(+605.5%) |
| Jun 2017 | - | $3.14 M(-836.4%) |
| Mar 2017 | - | -$425.80 K(-305.7%) |
| Dec 2016 | $207.00 K(-98.4%) | $207.00 K(-64.7%) |
| Sep 2016 | - | $586.80 K(-89.5%) |
| Jun 2016 | - | $5.57 M(-37.3%) |
| Mar 2016 | - | $8.88 M(-32.1%) |
| Dec 2015 | $13.08 M(-149.7%) | $13.08 M(-139.8%) |
| Sep 2015 | - | -$32.85 M(+1313.6%) |
| Jun 2015 | - | -$2.32 M(-92.1%) |
| Mar 2015 | - | -$29.52 M(+12.1%) |
| Dec 2014 | -$26.33 M(+47.5%) | -$26.33 M |
| Dec 2013 | -$17.85 M | - |
FAQ
- What is Avalo Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Avalo Therapeutics?
- What is Avalo Therapeutics annual shareholders equity year-on-year change?
- What is Avalo Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Avalo Therapeutics?
- What is Avalo Therapeutics quarterly shareholders equity year-on-year change?
What is Avalo Therapeutics annual stockholders equity?
The current annual shareholders equity of AVTX is $7.30 M
What is the all time high annual shareholders equity for Avalo Therapeutics?
Avalo Therapeutics all-time high annual stockholders equity is $27.86 M
What is Avalo Therapeutics annual shareholders equity year-on-year change?
Over the past year, AVTX annual stockholders equity has changed by +$18.22 M (+166.92%)
What is Avalo Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of AVTX is $21.08 M
What is the all time high quarterly shareholders equity for Avalo Therapeutics?
Avalo Therapeutics all-time high quarterly stockholders equity is $50.58 M
What is Avalo Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, AVTX quarterly stockholders equity has changed by +$34.68 M (+254.88%)